AnaptysBio Inc (ANAB) support and resistance · rev $234.6M
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
This page maps AnaptysBio Inc (ANAB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
ANAB currently screens at market cap $1.62B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ANAB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ANAB quote page for the session range and the stock page for the full model.
Not investment advice.